Michael Wormald is a patent agent in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovations practice. Michael assists in the preparation and prosecution of patent applications in addition to performing freedom-to-operate and patentability analyses for clients in the pharmaceutical, chemical, and biotechnology industries.
Prior to joining the firm, Michael was a member of the technology development group at Johns Hopkins Technology Ventures, where he assisted university faculty in developing and commercializing early stage inventions in the life sciences.
Michael received his Ph.D. in Pharmacology and Molecular Sciences from Johns Hopkins University and has a broad technical background, particularly in pharmacology, in vitro assay development, high-throughput screening, and synthetic organic chemistry.
Michael Wormald is a patent agent in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovations practice. Michael assists in the preparation and prosecution of patent applications in addition to performing freedom-to-operate and patentability analyses for clients in the pharmaceutical, chemical, and biotechnology industries.
Prior to joining the firm, Michael was a member of the technology development group at Johns Hopkins Technology Ventures, where he assisted university faculty in developing and commercializing early stage inventions in the life sciences.
Michael received his Ph.D. in Pharmacology and Molecular Sciences from Johns Hopkins University and has a broad technical background, particularly in pharmacology, in vitro assay development, high-throughput screening, and synthetic organic chemistry.
- Ph.D., Pharmacology and Molecular Sciences, Johns Hopkins University
- B.S., Biochemistry and Molecular Biology, University of Richmond, Virginia
- U.S. Patent and Trademark Office
- Ph.D., Pharmacology and Molecular Sciences, Johns Hopkins University
- B.S., Biochemistry and Molecular Biology, University of Richmond, Virginia
- U.S. Patent and Trademark Office
Select Publications
- Co-author, “Identification of Small-Molecule Inhibitors of Human Inositol Hexakisphosphate Kinases by High-Throughput Screening,” 4(2) ACS Pharmacol. Transl. Sci. 780-789, 2021
- Co-author, “Synthesis and characterization of novel isoform-selective IP6K1 inhibitors,” 29(19) Bioorg. Med. Chem. Lett., 2019
- Co-author, “Development of a homogenous high-throughput assay for inositol hexakisphosphate kinase 1 activity,” 12(11) PLoS One, 2017
Select Publications
- Co-author, “Identification of Small-Molecule Inhibitors of Human Inositol Hexakisphosphate Kinases by High-Throughput Screening,” 4(2) ACS Pharmacol. Transl. Sci. 780-789, 2021
- Co-author, “Synthesis and characterization of novel isoform-selective IP6K1 inhibitors,” 29(19) Bioorg. Med. Chem. Lett., 2019
- Co-author, “Development of a homogenous high-throughput assay for inositol hexakisphosphate kinase 1 activity,” 12(11) PLoS One, 2017
Biological Sciences and Biotechnology
- Biochemical assays
- Biochemistry
Therapeutics and Drug Discovery
- Drug conjugates
- Peptide therapeutics
- Pharmacodynamics
- Pharmacokinetics
- Pharmacology
- Small molecule synthesis
- Small molecules
Chemistry and Material Science
- Organic chemistry
Biological Sciences and Biotechnology
- Biochemical assays
- Biochemistry
Therapeutics and Drug Discovery
- Drug conjugates
- Peptide therapeutics
- Pharmacodynamics
- Pharmacokinetics
- Pharmacology
- Small molecule synthesis
- Small molecules
Chemistry and Material Science
- Organic chemistry
- Privacy Policy
- Terms of Use
- Accessibility